Related Experiment Video
Updated: Jul 13, 2026

Cell Subtype-specific Analysis of Neuronal Membrane Proteasome in Somatosensory Neurons
Published on: October 10, 2025
A high-dose bortezomib neuropathy with sensory ataxia and myelin involvement
Massimiliano Filosto1, Giuseppe Rossi, Anna Maria Pelizzari
1Clinical Neurology, Section for Neuromuscular Diseases and Neuropathies, University Hospital "Spedali Civili", Brescia, Italy. filosto@med.unibs.it
Abstract:
Bortezomib, a proteasome inhibitor used in the treatment of multiple myeloma, is known to induce an axonal, dose-dependent neuropathy clinically characterized by pain, paresthesias, burning dysesthesias and numbness. In this study, we describe a patient treated with high-dose bortezomib whose main clinical feature was severe sensory ataxia. Electrodiagnostic studies showed, other than axonal changes, myelin involvement.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Drug Toxicity: Dose-Dependent Reactions
Diabetic Neuropathy
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Drug toxicity: Idiosyncratic Reactions
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists